 

:347944A8-FA38-477F-368C-585132897798
””10 TCGA-CF—ABHX-OlA-PR Redﬁilted

IRB APPROVED

||||||||||||||||||||||||||||| |||||
lullilllllilllliilllllliiiiill|||||||||||||||||||||l|||||l|||| .
Lope» - 3

Clinical Case Report 6‘98“” - [Maw
”dost“! 92013

 

 

 

(For Collection of Cancerous Tissue)

lb

 

 

. 55/530/
‘ i . M05 ,
[Informed Consenli 5453536! 5 ! Cdﬁ~
’W 697. 8’

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT ”it;
FORM with the patient and answered any questions the patient had. The patient then signed the OE)
consent form as a free and voluntary act. A copy of this informed consent document will be retained at w
our institution.

'1;

lil’ame of Physician or Study coordinator ‘ Signature ‘ Bette

 

[ginical Information]

. . . . . GENERAL INFORMATION
Date of Birth ( _ 1'

a Single
Gender ' El Divorced El Widow Blood Pressure Heart Rate
Cl Male ‘

 

 

, .- ' ,' ' . HISTORYOFPRESENTILLNESS . . i L
ChiefComplalnts: AbWMd/C [7&7an )' JQUe/Lj Mglcoc’j l/VI buy/Hg

 

 

Symptoms: w 010344" [(95 5

 

Clinical Findings:

 

 

Performance Scale (Karnofsky Score):
a 100 Asymptomatic a 80-90 Symptomatic but Fully Ambulatory 0-70 Symptomatic, in bed less than 50% of day
D 40‘50 Symptomatic, in bed more than 50% of day, but 11 t bed ridden B 2030 Bed Ridden

 

 

CURRENT MEDICATIONS
Dose Route

 

PAST MEDICAL

 

 

 

 

 

 

OB/GYN HISTORY
Menopausal Status Date of First Menses # of Pregnancies
Ci Pie-menopausal i 3 ﬁat/W of {f 0 2
u Peri-Menopausal Date of'Last Menses # of Live Births
ﬁPost-menopausal [f 1 £6” deaf {j 7

 

 

 

Birth Control: D Condom :1 Oral Contraceptive (“w IUD

[Ii-Other:

 

El Hormone Replacement
Therapy:

 

Current Status
D YES NO

Status
El YES NO

Status
El YES

H Relative

SOCIAL HISTORY

Environmental

Smoki H

Alcohol
Drinks

Use
F

- FAMILY MEDICAL-

Duration

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Test Result l Date 1. .. Test Result Date
HIV Wegative Cl Positive: __v - CEA Cl Negative t3 Positive:
Hep B (pNegative D Positive: " CA 15-3 [:3 Negative El Positive:
Hep C ‘iQ’Negative Cl Positive: CA 19-9 D Negative :1 Positive:
APP Ci Ne ative [:1 Positive: PSA El Negative Ct Positive:
Other: D Negative El Positive: Other: El Negative D Positive:
BIT Cell Markers:

 

 

 

 

DIAGNOSTIC STUDIES

Ultrasound
x.
CT

MRI
B'

CLINICAL DIAGNOSIS

Clinical
./ D

Location of Involved L Location of Distant Metastasis

Date of
T2 N p M a Stage:

 

 

lTreatment Informationi

SURGICAL TREATMENT .
Procedure Date of Procedure

Tumor
Detailed Location

Extension of Tumor

L Nodes
Location of L Nodes # of L Nodes
Palpable, Non-Dissected Lymph Nodes

Dissected Lymph Nodes

Distant Metastasis
Detailed Location

Su
T N M

. NEOADJUVENT THERAPY or Molecular
reatment Dose Route Date
I To
To
T 0
To
To

 

WWW.

Pathology Form

 

[Specimen Information]

Collected by: _ Date: , 7 , fime:

M

Preserved by: _ Date; Time; .

 

 

SPECIMEN TYPE (# of samples provided)

 

Frozen Parafﬁn Block BIood/SerumlPlasma V Slide

 

 

 

 

 

 

 

 

 

 

 

Diseased Normal Diseased Normal Diseased Normal Diseased Normal
«4; P. 43 2 ,4; &
lTime to LN2 Time to Formalin ' Time to LN2 _ . V ' r

1 7 . min ,;/2 min min

 

 

 

PATHOLOGICAL DESCRIPTION ‘

Prima Tumor
Size Extension of Distance to NAT

X X cm cm

Nodes
Location . # Examined # Metastasized

Distant Metastasis
Detailed

 

 

m APPROVED

 

 

Consolidated Pathology Diagnosis

, roar:

 

 

 

 

 

 

 

 

 

Director. midiPaﬂIoiogy , V ,
iNTEGM'rED REPORTOFHNDINGSBYGJLLABOMTORSAND

 

